サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1259847

ニコチンアミドアデニンジヌクレオチドの世界市場 - 市場シェア、規模、動向、業界分析：グレード別、用途別、地域別、セグメント予測（2023年～2032年）

Nicotinamide Adenine Dinucleotide Market Share, Size, Trends, Industry Analysis Report, By Grade (Food Grade, Pharmaceutical Grade, and Others); By Application; By Region; Segment Forecast, 2023- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
ニコチンアミドアデニンジヌクレオチドの世界市場 - 市場シェア、規模、動向、業界分析：グレード別、用途別、地域別、セグメント予測（2023年～2032年）
出版日: 2023年03月01日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のニコチンアミドアデニンジヌクレオチドの市場規模は、2032年までに17億2,211万米ドルに達すると予測されています。

当レポートでは、世界のニコチンアミドアデニンジヌクレオチド市場について調査分析し、市場力学、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のニコチンアミドアデニンジヌクレオチド市場の考察

  • 業界のスナップショット
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
  • PESTLE分析
  • 業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のニコチンアミドアデニンジヌクレオチド市場：グレード別

  • 主な調査結果
  • イントロダクション
    • 世界のニコチンアミドアデニンジヌクレオチド市場：グレード別（2019年～2032年）
  • 食品グレード
  • 医薬品グレード
  • その他

第6章 世界のニコチンアミドアデニンジヌクレオチド市場：用途別

  • 主な調査結果
  • イントロダクション
    • 世界のニコチンアミドアデニンジヌクレオチド市場：用途別（2019年～2032年）
  • 栄養補助食品
  • 医薬品
  • アンチエイジング製品
  • その他

第7章 世界のニコチンアミドアデニンジヌクレオチド市場：地域別

  • 主な調査結果
  • イントロダクション
    • ニコチンアミドアデニンジヌクレオチド市場の評価：地域別（2019年～2032年）
  • 北米
    • 用途別
    • グレード別
    • 米国
    • カナダ
  • 欧州
    • 用途別
    • グレード別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋
    • 用途別
    • グレード別
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 用途別
    • グレード別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • 用途別
    • グレード別
    • メキシコ
    • ブラジル
    • アルゼンチン

第8章 競合情勢

  • 拡張と買収の分析
    • 拡張
    • 買収
  • パートナーシップ/コラボレーション/協定/展示会

第9章 企業プロファイル

  • Bontac Bio-engineering
  • Jubilant Life Sciences
  • Koninklijke DSM
  • Lasons India
  • Resonance Specialties
  • TCI Chemcials
  • Vertellus Holdings
  • Novo Nordisk
  • Catalent
  • Lonza Group
  • Zhejiang Lanbo Biotechnology
  • Otto Chemie
  • Himedia Laboratories
  • NutriScience Innovations
図表

List of Tables

  • Table 1 Global Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 2 Global Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 3 Nicotinamide Adenine Dinucleotide Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 5 North America: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 6 U.S.: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 7 U.S.: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 8 Canada: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 9 Canada: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 10 Europe: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 11 Europe: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 12 UK: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 13 UK: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 14 France: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 15 France: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 16 Germany: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 17 Germany: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 18 Italy: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 19 Italy: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 20 Spain: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 21 Spain: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 22 Netherlands: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 23 Netherlands: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 24 Russia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 25 Russia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 28 China: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 29 China: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 30 India: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 31 India: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 32 Malaysia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 33 Malaysia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 34 Japan: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 35 Japan: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 36 Indonesia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 37 Indonesia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 38 South Korea: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 39 South Korea: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 44 UAE: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 45 UAE: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 46 Israel: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 47 Israel: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 48 South Africa: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 49 South Africa: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 50 Latin America: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 51 Latin America: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 52 Mexico: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 53 Mexico: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 54 Brazil: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 55 Brazil: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 56 Argentina: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 57 Argentina: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)

List of Figures

Figure 1 Global Nicotinamide Adenine Dinucleotide Market, 2019-2032 (USD Million)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top-Down & Bottom-Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Application

Figure 7 Global Nicotinamide Adenine Dinucleotide Market, by Application, 2022 & 2032 (USD Million)

Figure 8 Market by Grade

Figure 9 Global Nicotinamide Adenine Dinucleotide Market, by Grade, 2022 & 2032 (USD Million)

Figure 10 Nicotinamide Adenine Dinucleotide Market Assessment, By Geography, 2019-2032 (USD Million)

Figure 11 Strategic Analysis - Nicotinamide Adenine Dinucleotide Market

目次
Product Code: PM3098

The global nicotinamide adenine dinucleotide market size is expected to reach USD 1,722.11 million by 2032, according to a new study by Polaris Market Research. The report "Nicotinamide Adenine Dinucleotide Market Share, Size, Trends, Industry Analysis Report, By Grade (Food Grade, Pharmaceutical Grade, and Others); By Application; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing product penetration as a key supplement for a variety of food ingredients because of the NAD's antioxidant properties coupled with the surge in consumer awareness regarding the health benefits of the product and continuously growing healthcare spending capacity of people across both developed and developing countries are key factors expected to boost the market growth. Moreover, the increasing focus of major market players on developing more advanced and innovative solutions to tackle various issues associated with human health through heavily investing in R&D activities is also creating huge growth opportunities in the market.

NAD+ has been studied extensively across the globe over the last few decades and continues to receive current research attention as several new roles and functions of this cofactor have significantly emerged in the regulation of protein modifications that could help regulate cellular metabolism and a wide range of cellular events. Recent studies have also shown that NAD+ levels can profoundly eliminate or reduce cell damage in catabolic tissue, including the brain. Therefore, the promotion of intracellular NAD+ anabolism shows promising market growth.

Moreover, the NAD+ concentration increases under various conditions associated with reduced energy loads, including glucose deprivation, fasting, caloric restriction, and exercise. Apart from this, these levels are highly elevated under conditions of increased life span or health span, representing a major contributor to aging. Thus, supplementation with the product and its precursors might define a potential therapeutic strategy to mediate protection against the accumulation of inflammation and highly volatile ROS during aging.

Nicotinamide Adenine Dinucleotide Market Report Highlights:

Food grade segment accounted for over considerable global market share in 2022, which is mainly accelerated by its growing adoption as a substrate across various biological processes including DNA repair

Dietary supplements segment dominated the global market in 2022, on account of the widespread adoption of product as an alternative for vitamins and having the ability to help in living longer and healthier lives

Asia Pacific region is expected to witness highest growth rate throughout the forecast period, owing to increasing consumer proliferation for improving immunization and high product adoption across the pharma sector

The global key market players include Jubilant Life Sciences, TCI Chemicals, Vertellus Holdings, Zhenjiang Lanbo Biotechnology, Himedia Laboratories, and Catalent.

Polaris Market Research has segmented the nicotinamide adenine dinucleotide market report based on grade, application, and region:

Nicotinamide Adenine Dinucleotide, Grade Outlook (Revenue - USD Million, 2019 - 2032)

Food Grade

Pharmaceutical Grade

Others

Nicotinamide Adenine Dinucleotide, Application Outlook (Revenue - USD Million, 2019 - 2032)

Dietary Supplements

Pharmaceuticals

Anti-aging Products

Others

  • Nicotinamide Adenine Dinucleotide, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Nicotinamide Adenine Dinucleotide Market Insights

  • 4.1. Nicotinamide Adenine Dinucleotide Market - Industry Snapshot
  • 4.2. Nicotinamide Adenine Dinucleotide Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing number of product applications in biochemistry
      • 4.2.1.2. Rising consumer demand for anti-aging products
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Government regulations on dosage
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Nicotinamide Adenine Dinucleotide Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Nicotinamide Adenine Dinucleotide Market, by Grade

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Nicotinamide Adenine Dinucleotide, by Grade, 2019-2032 (USD Million)
  • 5.3. Food Grade
    • 5.3.1. Global Nicotinamide Adenine Dinucleotide Market, by Food Grade, by Region, 2019-2032 (USD Million)
  • 5.4. Pharmaceutical Grade
    • 5.4.1. Global Nicotinamide Adenine Dinucleotide Market, by Pharmaceutical Grade, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Nicotinamide Adenine Dinucleotide Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Nicotinamide Adenine Dinucleotide Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • 6.3. Dietary Supplements
    • 6.3.1. Global Nicotinamide Adenine Dinucleotide Market, by Dietary Supplements, by Region, 2019-2032 (USD Million)
  • 6.4. Pharmaceuticals
    • 6.4.1. Global Nicotinamide Adenine Dinucleotide Market, by Pharmaceuticals, by Region, 2019-2032 (USD Million)
  • 6.5. Anti-aging Products
    • 6.5.1. Global Nicotinamide Adenine Dinucleotide Market, by Anti-aging Products, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Nicotinamide Adenine Dinucleotide Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Nicotinamide Adenine Dinucleotide Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Nicotinamide Adenine Dinucleotide Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Nicotinamide Adenine Dinucleotide Market - North America
    • 7.3.1. North America: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
    • 7.3.2. North America: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.3.3. Nicotinamide Adenine Dinucleotide Market - U.S.
      • 7.3.3.1. U.S.: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.3.4. Nicotinamide Adenine Dinucleotide Market - Canada
      • 7.3.4.1. Canada: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • 7.4. Nicotinamide Adenine Dinucleotide Market - Europe
    • 7.4.1. Europe: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
    • 7.4.2. Europe: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.3. Nicotinamide Adenine Dinucleotide Market - UK
      • 7.4.3.1. UK: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.4. Nicotinamide Adenine Dinucleotide Market - France
      • 7.4.4.1. France: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.4.2. France: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.5. Nicotinamide Adenine Dinucleotide Market - Germany
      • 7.4.5.1. Germany: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.6. Nicotinamide Adenine Dinucleotide Market - Italy
      • 7.4.6.1. Italy: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.7. Nicotinamide Adenine Dinucleotide Market - Spain
      • 7.4.7.1. Spain: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.8. Nicotinamide Adenine Dinucleotide Market - Netherlands
      • 7.4.8.1. Netherlands: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.9. Nicotinamide Adenine Dinucleotide Market - Russia
      • 7.4.9.1. Russia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • 7.5. Nicotinamide Adenine Dinucleotide Market - Asia Pacific
    • 7.5.1. Asia Pacific: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.3. Nicotinamide Adenine Dinucleotide Market - China
      • 7.5.3.1. China: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.3.2. China: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.4. Nicotinamide Adenine Dinucleotide Market - India
      • 7.5.4.1. India: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.4.2. India: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.5. Nicotinamide Adenine Dinucleotide Market - Malaysia
      • 7.5.5.1. Malaysia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.6. Nicotinamide Adenine Dinucleotide Market - Japan
      • 7.5.6.1. Japan: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.7. Nicotinamide Adenine Dinucleotide Market - Indonesia
      • 7.5.7.1. Indonesia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.8. Nicotinamide Adenine Dinucleotide Market - South Korea
      • 7.5.8.1. South Korea: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • 7.6. Nicotinamide Adenine Dinucleotide Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.6.3. Nicotinamide Adenine Dinucleotide Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.6.4. Nicotinamide Adenine Dinucleotide Market - UAE
      • 7.6.4.1. UAE: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.6.5. Nicotinamide Adenine Dinucleotide Market - Israel
      • 7.6.5.1. Israel: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.6.6. Nicotinamide Adenine Dinucleotide Market - South Africa
      • 7.6.6.1. South Africa: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • 7.7. Nicotinamide Adenine Dinucleotide Market - Latin America
    • 7.7.1. Latin America: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.7.3. Nicotinamide Adenine Dinucleotide Market - Mexico
      • 7.7.3.1. Mexico: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.7.4. Nicotinamide Adenine Dinucleotide Market - Brazil
      • 7.7.4.1. Brazil: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.7.5. Nicotinamide Adenine Dinucleotide Market - Argentina
      • 7.7.5.1. Argentina: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Bontac Bio-engineering
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Jubilant Life Sciences
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Koninklijke DSM
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Lasons India
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Resonance Specialties
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. TCI Chemcials
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Vertellus Holdings
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Novo Nordisk
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Catalent
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Lonza Group
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Zhejiang Lanbo Biotechnology
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Otto Chemie
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Himedia Laboratories
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. NutriScience Innovations
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development